SCHEMBL455192

SCHEMBL455192

CCc1c[c]ccc1F

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14842441 0.85 TAAR1 (0.31)
SCHEMBL63751 0.84
SCHEMBL15008845 0.81 TYR (0.39)
SCHEMBL22095186 0.81
SCHEMBL1476654 0.80 ALDH1A1 (0.40)
SCHEMBL3831752 0.80 MCL1 (0.41)
SCHEMBL58401 0.80 GABRA1 (0.33)
SCHEMBL15939878 0.80 CA1 (0.35)
SCHEMBL1477884 0.80 MPO (0.33)
SCHEMBL28336992 0.80 TYR (0.40)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 113 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023076259-A1 TRIAZOLOPYRIDAZINE COMPOUNDS USEFUL AS RAC1 INHIBITORS REVERE PHARMACEUTICALS (US) 2023-05-04 WO claimed
CN-101189230-A Heterocyclic antiviral compounds ROCHE PALO ALTO LLC (CH) 2008-05-28 CN claimed
US-7326705-B2 Heterocyclic sodium/proton exchange inhibitors and method BRISTOL-MYERS SQUIBB COMPANY (US) 2008-02-05 US claimed
EP-1879885-A1 HETEROCYCLIC ANTIVIRAL COMPOUNDS F. Hoffmann-Roche AG (CH) 2008-01-23 EP claimed
WO-2006117306-A1 HETEROCYCLIC ANTIVIRAL COMPOUNDS F. HOFFMANN-LA ROCHE AG (CH) 2006-11-09 WO claimed
US-20050137216-A1 Heterocyclic sodium/proton exchange inhibitors and method AHMAD SALEEM (US) 2005-06-23 US claimed
CN-1468232-A Heterocyclic sodium/proton exchange inhibitors and method ����˹�ж�-����˹˹������˾ 2004-01-14 CN claimed
EP-1224183-A2 HETEROCYCLIC SODIUM/PROTON EXCHANGE INHIBITORS AND METHOD BRISTOL-MYERS SQUIBB COMPANY (US) 2002-07-24 EP claimed
WO-2001027107-A2 HETEROCYCLIC SODIUM/PROTON EXCHANGE INHIBITORS AND METHOD BRISTOL-MYERS SQUIBB COMPANY (US) 2001-04-19 WO claimed
WO-2023076259-A1 TRIAZOLOPYRIDAZINE COMPOUNDS USEFUL AS RAC1 INHIBITORS REVERE PHARMACEUTICALS (US) 2023-05-04 WO disclosed
CN-110536892-A New bicyclic pyrazole derivative BAYER ANIMAL HEALTH GMBH 2019-12-03 CN disclosed
EP-2900645-B1 HERBICIDAL AND FUNGICIDAL 3-PHENYLISOXAZOLIN DERIVATIVES BAYER CROPSCIENCE AG (DE) 2019-08-21 EP disclosed
CN-106458878-B 2- cyano -3- cyclopropyl -3- hydroxy-ns-thio the acrylamide derivative of aryl - 艾格埃克斯制药有限公司 2018-08-31 CN disclosed
EP-3045450-B1 INTERMEDIATE COMPOUNDS IN PROCESSES FOR PRODUCING PYRIDAZINONE COMPOUNDS SUMITOMO CHEMICAL CO (JP) 2018-02-07 EP disclosed
EP-0406661-A1 Substituted 3-aminosydnonimines, process for their preparation, and their use CASSELLA Aktiengesellschaft (DE) 1991-01-09 EP disclosed
EP-0367036-A2 Substituted 3-aminosydnonimines, process for their preparation and their use CASSELLA Aktiengesellschaft (DE) 1990-05-09 EP disclosed
EP-0327808-A1 Substituted 3-aminosydnonimines, process for their preparation and their use CASSELLA Aktiengesellschaft (DE) 1989-08-16 EP disclosed
EP-0101974-B1 THIADIAZINONES, PROCESS FOR THEIR PREPARATION AND FUNGICIDES CONTAINING THEM BASF Aktiengesellschaft (DE) 1986-01-02 EP disclosed
US-4496563-A Fungicidal thiadiazinones BASF AKTIENGESELLSCHAFT (DE) 1985-01-29 US disclosed
EP-0101974-A1 Thiadiazinones, process for their preparation and fungicides containing them BASF Aktiengesellschaft (DE) 1984-03-07 EP disclosed